July 28, 2020
By In Press
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Inflammation in the case Covid-19: New study provides evidence of efficacy of CBD
Researchers never tire of looking for new approaches to the therapy of Covid-19. The majority of corona infections – the cause of Covid-19 – are mild. However, a considerable number of patients require intensive medical care and, in extreme cases, even ventilation.
Publish date: July 2, 2020
Two new studies offer positive news about medical cannabis, suggesting that marijuana products improve physical and cognitive symptoms, boost quality of life, and rarely produce signs of problematic use.
